Elevance Health Currently Down Nine Consecutive Days, on Track for Longest Losing Streak Since July 2010 -- Data Talk
Dow Jones2026/09/30 14:21Elevance Health, Inc. (ELV) is currently at $390.26, down $2.48 or 0.63%
--Would be lowest close since Aug. 17, 2026, when it closed at $390.24
--On pace for largest percent decrease since Sept. 23, 2026, when it fell 0.96%
--Currently down 11 of the past 12 days
--Currently down nine consecutive days; down 5.79% over this period
--Longest losing streak since July 2, 2010, when it fell for nine straight trading days
--Worst nine day stretch since the nine days ending July 27, 2026, when it fell 11.35%
--Down 0.58% month-to-date; on pace for worst month since July 2026, when it fell 2.82%
--Up 11.33% year-to-date
--Down 30.6% from its all-time closing high of $562.29 on Sept. 3, 2024
--Up 17.31% from 52 weeks ago (Oct. 1, 2025), when it closed at $332.66
--Down 8.56% from its 52-week closing high of $426.79 on July 14, 2026
--Up 39.01% from its 52-week closing low of $280.74 on March 9, 2026
--Traded as low as $386.75; lowest intraday level since Aug. 12, 2026, when it hit $385.84
--Down 1.52% at today's intraday low; largest intraday percent decrease since Sept. 22, 2026, when it fell as much as 1.94%
All data as of 10:19:03 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 30, 2026 10:21 ET (14:21 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BICO completes integration of Cellenion into SCIENION, retires Cellenion brand
Japanese Yen draws support from hot Tokyo CPI as USD bulls await US NFP report
A global bond market sell-off sweeps across the world, pushing the dollar to a 17-month high; the euro becomes the hardest-hit currency.
On Friday, the US dollar hovered near a 17-month high and is set to rise for the third consecutive week.
Japan’s Katayama says will beef up efforts to promote version of doge review of subsidies, funds
